- LeMaitre Vascular (LMAT +2.3%) says it's acquired the assets of InaVein for $2.5M.
- The purchase price represents 1.1X of InaVein's 2012 sales, and potential earn-out payments in 2014 and 2015 based on the performance of the acquired business and regulatory approval in China.
- InaVein owned and marketed the TRIVEX System, which carries an attractive 60% - 70% gross margin.
LeMaitre Vascular buys assets of InaVein for $2.5M
Aug 28 2013, 13:19 ET